| Issuer / Guarantor | CRISPR Therapeutics AG |
|---|---|
| Size | USD 550mn |
| Type | Convertible |
| Leads | JP Morgan, Jefferies |
| Maturity | 01 Mar 2031 (5 years) |
| Coupon | 1.125% (0.75 - 1.25%) |
| Premium | 45% (35 - 40%) |
| Calls | NC3; PC @ 130% w table MW |
| Puts | t/o @ 100% |
| Div protection | Ratio adjustment (Full) |
| T/o protection | Make-whole table |
| CoCo | None |
| Announced | 10 Mar 2026 |